Temporally modulated pulsed proton re-irradiation (TMPPR) for recurrent high-grade gliomas

被引:1
|
作者
La Rosa, Alonso [1 ]
Gutierrez, Alonso N. [1 ,2 ]
Odia, Yazmin [2 ,3 ]
McDermott, Michael W. [2 ,4 ]
Ahluwalia, Manmeet S. [2 ,5 ]
Mehta, Minesh P. [1 ,2 ]
Kotecha, Rupesh [1 ,2 ,6 ]
机构
[1] Baptist Hlth South Florida, Miami Canc Inst, Dept Radiat Oncol, Miami, FL USA
[2] Florida Int Univ, Herbert Wertheim Coll Med, Miami, FL USA
[3] Baptist Hlth South Florida, Miami Canc Inst, Dept Neurooncol, Miami, FL USA
[4] Baptist Hlth South Florida, Miami Neurosci Inst, Dept Neurosurg, Miami, FL 33176 USA
[5] Baptist Hlth South Florida, Miami Canc Inst, Dept Med Oncol, Miami, FL USA
[6] Baptist Hlth South Florida, Miami Canc Inst, 1R203,8900 N Kendall Dr, Miami, FL 33176 USA
关键词
PHASE-II TRIAL; BEVACIZUMAB; RADIOTHERAPY;
D O I
10.1093/noajnl/vdad074
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We present the first known case of a multi-recurrent highgrade glioma patient, which after multiple salvage strategies, was treated with a novel radiation therapy technique, "temporally modulated pulsed proton re-irradiation" (TMPPR). This proton therapy (PT) technique has the radiobiological property to allow an enhanced tumor cell death and an increased normal cell sublethal repair by splitting the radiation dose into smaller subfractions delivered as pulses, with the novelty of using PT for its administration. The response to the treatment was impressive, as a complete response (CR) was achieved, minimal treatment-related toxicities were seen, and no deterioration in neurocognitive function was observed.
引用
收藏
页数:3
相关论文
共 50 条
  • [1] Proton therapy re-irradiation for large-volume recurrent high-grade gliomas
    Amelio, D.
    Widesott, L.
    Maines, F.
    Fellin, F.
    Righetto, R.
    Vennarini, S.
    Rombi, B.
    Cianchetti, M.
    Dionisi, F.
    Donner, D.
    Rozzanigo, U.
    Schwarz, M.
    Chierichetti, F.
    Galligioni, E.
    Amichetti, M.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S543 - S543
  • [2] Concurrent hyperthermia and re-irradiation for recurrent high-grade gliomas
    Heo, J.
    Kim, S. H.
    Oh, Y. T.
    Chun, M.
    Noh, O. K.
    [J]. NEOPLASMA, 2017, 64 (05) : 803 - 808
  • [3] Timing of re-irradiation in recurrent high-grade gliomas: a single institution study
    Zemlin, A.
    Maertens, B.
    Wiese, B.
    Merten, R.
    Steinmann, D.
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2018, 138 (03) : 571 - 579
  • [4] Timing of re-irradiation in recurrent high-grade gliomas: a single institution study
    A. Zemlin
    B. Märtens
    B. Wiese
    R. Merten
    D. Steinmann
    [J]. Journal of Neuro-Oncology, 2018, 138 : 571 - 579
  • [5] Re-Irradiation with high-dose stereotactic radiotherapy for recurrent High-grade Gliomas
    Mousli, A.
    Bocquet, V.
    Frederick, B.
    Louis, C.
    Biver, S.
    Philippi, S.
    Nickers, P.
    Untereiner, M.
    Vogin, G.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S864 - S864
  • [6] Re-irradiation with and without bevacizumab as salvage therapy for recurrent or progressive high-grade gliomas
    Thomas Hundsberger
    Detlef Brügge
    Paul M. Putora
    Patrik Weder
    Johannes Weber
    Ludwig Plasswilm
    [J]. Journal of Neuro-Oncology, 2013, 112 : 133 - 139
  • [7] Re-irradiation with and without bevacizumab as salvage therapy for recurrent or progressive high-grade gliomas
    Hundsberger, Thomas
    Bruegge, Detlef
    Putora, Paul M.
    Weder, Patrik
    Weber, Johannes
    Plasswilm, Ludwig
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2013, 112 (01) : 133 - 139
  • [8] Comparison of risk scores for re-irradiation of patients with recurrent high-grade gliomas (HGG)
    Scholz, H.
    Combs, S. E.
    Kessel, K. A.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S470 - S470
  • [9] Re-Irradiation with Bevacizumab in recurrent high-grade Glioma
    Niyazi, M.
    Ganswindt, U.
    Schwarz, S. B.
    Schnell, O.
    Belka, C.
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2012, 188 : 75 - 75
  • [10] Re-irradiation alternatives for recurrent high-grade glioma
    Dong, Yuanli
    Fu, Chengrui
    Guan, Hui
    Zhang, Tianyi
    Zhang, Zicheng
    Zhou, Tao
    Li, Baosheng
    [J]. ONCOLOGY LETTERS, 2016, 12 (04) : 2261 - 2270